Epigenetic reprogramming induced prostaglandin E2 accumulation via overactivated arachidonic acid metabolism during trastuzumab resistance formation of HER2-positive breast cancer

被引：0
|
作者：
Yin, Y. [1 ]
Duan, N. [1 ]
Hua, Y. [1 ]
机构：
[1] Nanjing Med Univ, Dept Oncol, Jiangsu Prov Hosp, Affiliated Hosp 1, Nanjing, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1016/j.annonc.2023.09.1535
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
32P
引用
收藏
页码：S196 / S197
页数：2
相关论文
共 50 条
  • [31] Trastuzumab interruption and treatment-induced cardiotoxicity in early HER2-positive breast cancer
    Anthony F. Yu
    Nandini U. Yadav
    Betty Y. Lung
    Anne A. Eaton
    Howard T. Thaler
    Clifford A. Hudis
    Chau T. Dang
    Richard M. Steingart
    Breast Cancer Research and Treatment, 2015, 149 : 489 - 495
  • [32] A Prospective Study About Trastuzumab-induced Cardiotoxicity in HER2-positive Breast Cancer
    Ben Kridis, Wala
    Sghaier, Syrine
    Charfeddine, Salma
    Toumi, Nabil
    Daoud, Jamel
    Kammoun, Samir
    Khanfir, Afef
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (07): : 510 - 516
  • [33] Takotsubo Syndrome during Pertuzumab and Trastuzumab Therapy for HER2-Positive Metastatic Breast Cancer
    Irelli, Azzurra
    Ceriello, Laura
    Patruno, Leonardo Valerio
    Tessitore, Alessandra
    Alesse, Edoardo
    Cannita, Katia
    Fabiani, Donatello
    BIOMEDICINES, 2024, 12 (01)
  • [34] Trastuzumab interruption and treatment-induced cardiotoxicity in early HER2-positive breast cancer
    Yu, Anthony F.
    Yadav, Nandini U.
    Lung, Betty Y.
    Eaton, Anne A.
    Thaler, Howard T.
    Hudis, Clifford A.
    Dang, Chau T.
    Steingart, Richard M.
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 149 (02) : 489 - 495
  • [35] Trastuzumab-induced cardiotoxicity in Uruguayan HER2-positive breast cancer patients.
    Schiavone, Andrea
    Diaz, Mariana
    Camejo, Natalia
    Reborido, Natalia
    Vazquez, Horacio
    Parma, Gabriel
    Vazquez, Alvaro
    Castillo, Cecilia
    Krygier, Gabriel David
    Delgado, Lucia Beatriz
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (28)
  • [36] TRAF4 hyperactivates HER2 signaling and contributes to Trastuzumab resistance in HER2-positive breast cancer
    Gu, Yayun
    Gao, Huanyao
    Zhang, Huan
    John, August
    Zhu, Xiujuan
    Shivaram, Suganti
    Yu, Jia
    Weinshilboum, Richard M.
    Wang, Liewei
    ONCOGENE, 2022, 41 (35) : 4119 - 4129
  • [37] TRAF4 hyperactivates HER2 signaling and contributes to Trastuzumab resistance in HER2-positive breast cancer
    Yayun Gu
    Huanyao Gao
    Huan Zhang
    August John
    Xiujuan Zhu
    Suganti Shivaram
    Jia Yu
    Richard M. Weinshilboum
    Liewei Wang
    Oncogene, 2022, 41 : 4119 - 4129
  • [38] β-Escin eradicates cancer stem-like population in HER2-positive breast cancer with trastuzumab resistance
    Park, Soeun
    Park, Minsu
    Ko, Dongmi
    Kim, Seongjae
    Seo, Juyeon
    Dal Nam, Kee
    Jung, Eunsun
    Kang, Yong Koo
    Jang, Seojin
    Seock, So Ra
    Kim, Yoon-Jae
    Kim, Ji Young
    Seo, Jae Hong
    Park, Jaeyoun
    CANCER RESEARCH, 2023, 83 (07)
  • [39] Trastuzumab Resistance in Patients With HER2-Positive Advanced Breast Cancer: Results From the SONABRE Registry
    Ibragimova, Khava I. E.
    Geurts, Sandra M. E.
    Laczko, David
    Meegdes, Marissa
    Erdkamp, Frans
    Heijns, Joan B.
    Tol, Jolien
    Vriens, Birgit E. P. J.
    Aaldering, Kirsten N. A.
    Dercksen, Marcus W.
    Pepels, Manon J. A. E.
    Peters, Natascha A. J. B.
    van de Winkel, Linda M. H.
    van de Wouw, Agnes J.
    de Fallois, Aude
    van Kats, Maartje A. C. E.
    Tjan-Heijnen, Vivianne C. G.
    CLINICAL BREAST CANCER, 2024, 24 (02) : 103 - 111
  • [40] Unraveling trastuzumab emtansine resistance in HER2-positive advanced breast cancer: GEICAM KATIA study
    Rojo Todo, F.
    Stradella, A.
    Garcia-Saenz, J. A.
    Bermejo De Las Heras, B.
    Alfonso Romero, J. L.
    Barnadas, A.
    Izarzugaza Peron, Y.
    Alba, E.
    Lopez-Tarruella, S.
    Henao-Carrasco, F.
    Carrasco, E.
    Caballero, R.
    Del Campo, M.
    ANNALS OF ONCOLOGY, 2020, 31 : S391 - S391
12345